Tano, Jhon Michael .
HRN: 09-53-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/07/2024
02/07/2024
IV
120
Q12h
Punctured Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes